We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDYG icon
1176
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.78B
$239K ﹤0.01%
2,725
WABC icon
1177
Westamerica Bancorp
WABC
$1.39B
$239K ﹤0.01%
+4,826
New +$245K
CRL icon
1178
Charles River Laboratories
CRL
$11.5B
$238K ﹤0.01%
1,210
+105
+10% +$21.8K
BHE icon
1179
Benchmark Electronics
BHE
$2.59B
$238K ﹤0.01%
+5,363
New +$224K
SHG icon
1180
Shinhan Financial Group
SHG
$32.2B
$237K ﹤0.01%
+5,603
New +$229K
FE icon
1181
FirstEnergy
FE
$28.9B
$237K ﹤0.01%
5,337
-52
-1% -$2.19K
VPL icon
1182
Vanguard FTSE Pacific ETF
VPL
$7.8B
$237K ﹤0.01%
3,018
KB icon
1183
KB Financial Group
KB
$39.6B
$236K ﹤0.01%
+3,822
New +$237K
SNSR icon
1184
Global X Internet of Things ETF
SNSR
$213M
$236K ﹤0.01%
6,793
-1,853
-21% -$64.4K
CMT icon
1185
Core Molding Technologies
CMT
$199M
$235K ﹤0.01%
13,658
HLNE icon
1186
Hamilton Lane
HLNE
$3.85B
$233K ﹤0.01%
1,386
-659
-32% -$95.4K
BAM icon
1187
Brookfield Asset Management
BAM
$75.2B
$232K ﹤0.01%
4,907
-559
-10% -$23.4K
VNT icon
1188
Vontier
VNT
$4.57B
$229K ﹤0.01%
6,786
-20,959
-76% -$745K
ASB icon
1189
Associated Banc-Corp
ASB
$5.83B
$229K ﹤0.01%
10,625
AVAV icon
1190
AeroVironment
AVAV
$7.38B
$229K ﹤0.01%
+1,141
New +$205K
AIZ icon
1191
Assurant
AIZ
$14B
$229K ﹤0.01%
+1,150
New +$210K
COIN icon
1192
Coinbase
COIN
$43.2B
$227K ﹤0.01%
1,275
-18
-1% -$3.6K
MAA icon
1193
Mid-America Apartment Communities
MAA
$16B
$226K ﹤0.01%
1,425
-192
-12% -$29.3K
VLUE icon
1194
iShares MSCI USA Value Factor ETF
VLUE
$9.2B
$226K ﹤0.01%
2,070
MCY icon
1195
Mercury Insurance
MCY
$6.08B
$225K ﹤0.01%
+3,570
New +$212K
VFC icon
1196
VF Corp
VFC
$5.98B
$225K ﹤0.01%
11,267
+440
+4% +$7.37K
FOUR icon
1197
Shift4
FOUR
$4.42B
$225K ﹤0.01%
2,536
-236
-9% -$17.9K
ASX icon
1198
ASE Group
ASX
$70.1B
$225K ﹤0.01%
23,017
-1,206
-5% -$12.2K
PHYS icon
1199
Sprott Physical Gold
PHYS
$14.4B
$224K ﹤0.01%
11,000
-2,550
-19% -$49.1K
BFAM icon
1200
Bright Horizons
BFAM
$4.31B
$224K ﹤0.01%
+1,597
New +$207K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.